Rosiglitazone attenuates atherosclerosis and increases high-density lipoprotein function in atherosclerotic rabbits

Rosiglitazone has been found to have anti-atherogenic effects and to increase serum high-density lipoprotein (HDL) cholesterol (HDL-C) levels. However, in vivo studies investigating the regulation of adenosine triphosphate-binding cassette transporter A1 (ABCA1) and scavenger receptor class B type I...

Descripción completa

Detalles Bibliográficos
Autores principales: LI, CHEN, TU, YAN, LIU, TING-RONG, GUO, ZHI-GANG, XIE, DI, ZHONG, JIAN-KAI, FAN, YONG-ZHEN, LAI, WEN-YAN
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314417/
https://www.ncbi.nlm.nih.gov/pubmed/25604880
http://dx.doi.org/10.3892/ijmm.2015.2072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314417/
https://www.ncbi.nlm.nih.gov/pubmed/25604880
http://dx.doi.org/10.3892/ijmm.2015.2072

Ejemplares similares